Work

Riluzole prodrugs for melanoma and ALS: Design, synthesis, and in vitro metabolic profiling

Year: 2012

Type: article

Source: Bioorganic & Medicinal Chemistry

DOI: 10.1016/j.bmc.2012.07.004

Authors: Mark E. McDonnell, Matthew D. Vera, Benjamin E. Blass, Jeffrey C. Pelletier, Richard C. King, Carmen Fernandez-Metzler, Garry R. Smith, Jay Wrobel, Suzie Chen, Brian A. Wall, Allen B. Reitz

Institutions: Fox Chase Chemical Diversity Center, Rutgers, The State University of New Jersey

Language: English

Topic: Pharmacogenetics and Drug Metabolism

Subfield: Pharmacology

Field: Pharmacology, Toxicology and Pharmaceutics

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: green

Funders: National Institutes of Health, National Cancer Institute

Awards: Riluzole Prodrugs for Melanoma and ALS, Riluzole Prodrugs for Melanoma and ALS

OpenAlex ID: W2011324232

FWCI: 1.986

Cites: 31

Cited by: 30

Related to: 10